APP and Alzheimer disease: This model expresses APP Swedish, APP Iberian, and APP Arctic at WT levels as seen in human patients by using the endogenous APP promoter for gene expression; meaning the AD effects seen are due to mutation and not overexpression from an artificial promoter [35].